Search for a doctor

Jonathan B. Ashman, M.D., Ph.D.

  1. Radiation Oncologist
Request an Appointment

Publications

  1. Vern-Gross TZ, Laughlin BS, Kough K, Ernst B, Langley N, Rule WG, Patel SH, Ashman JB. Implementation of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education. J Palliat Med. 2024 Feb; 27 (2):231-235
    View PubMed
  2. Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett C. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Pract Radiat Oncol 2024 Jan-Feb; 14 (1):28-46 Epub 2023 Nov 02
    View PubMed
  3. Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett C. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Ann Thorac Surg 2024 Jan; 117 (1):15-32 Epub 2023 Nov 02
    View PubMed
  4. Zaniletti I, Gunn HJ, Hallemeier CL, Laughlin BS, Leavitt TR, Haddock MG, Merrell KW, Leenstra JL, May BC, Ashman JB, DeWees TA. Determining the Minimal Clinically Important Difference of the Functional Assessment of Cancer Therapy Hepatobiliary Questionnaire to Evaluate the Change in the Quality of Life of Patients With Pancreatic Cancer During Radiation Therapy. Int J Radiat Oncol Biol Phys. 2024 Jan 1; 118 (1):137-141 Epub 2023 Aug 14
    View PubMed
  5. Zaniletti I, Gunn HJ, Hallemeier CL, Laughlin BS, Leavitt TR, Haddock MG, Merrell KW, Leenstra JL, May BC, Ashman JB, DeWees TA. Determining the minimal clinically important difference of the functional assessment of cancer therapy hepatobiliary questionnaire to evaluate the change in the quality of life of patients with pancreatic cancer during radiation therapy. International Journal of Radiation Oncology Biology Physics. 2024 Jan; 118 (1):137-41
  6. Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, Ashman JB, Schild SE, Grams MP, Lucido JJ, Shen KR, Cassivi SD, Wigle D, Nichols FC, Blackmon S, Tapias LF, Callstrom MR, Owen D. Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Chest. 2023 Dec 14 [Epub ahead of print]
    View PubMed
  7. Laughlin BS, Langley N, Patel SH, Kough K, Ernst B, Ashman JB, Rule WG, Vern-Gross TZ. Attitudes and Perception of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education. J Cancer Educ. 2023 Dec; 38 (6):1786-1791 Epub 2023 June 22
    View PubMed
  8. Huntoon K, Anderson SK, Ballman KV, Twohy E, Dooley K, Jiang W, An Y, Li J, von Roemeling C, Qie Y, Ross OA, Cerhan JH, Whitton AC, Greenspoon JN, Parney IF, Ashman JB, Bahary JP, Hadjipanayis C, Urbanic JJ, Farace E, Khuntia D, Laack NN, Brown PD, Roberge D, Kim BYS. Association of circulating markers with cognitive decline after radiation therapy for brain metastasis. Neuro Oncol. 2023 Jun 2; 25 (6):1123-1131
    View PubMed
  9. Shen J, Robertson DG, Bues M, Shipulin K, Liu W, Stoker J, Ashman JB, Lara P, Keole SR, Wong W, Vora SA. Technical note: Comprehensive evaluations of gantry and couch rotation isocentricities for implementing proton stereotactic radiosurgery. Med Phys. 2023 Jun; 50 (6):3359-3367 Epub 2023 Apr 06
    View PubMed
  10. Laughlin BS, Golafshar M, Prince M, Liu W, Kutyreff CJ, Ahmed SK, Vern Gross TZ, Haddock M, Petersen I, DeWees TA, Ashman JB. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma. Acta Oncol. 2023 May; 62 (5):473-479 Epub 2023 May 08
    View PubMed
  11. Hoppe BS, Petersen IA, Wilke BK, DeWees TA, Imai R, Hug EB, Fiore MR, Debus J, Fossati P, Yamada S, Orlandi E, Zhang Q, Bao C, Seidensaal K, May BC, Harrell AC, Houdek MT, Vallow LA, Rose PS, Haddock MG, Ashman JB, Goulding KA, Attia S, Krishnan S, Mahajan A, Foote RL, Laack NN, Keole SR, Beltran CJ, Welch EM, Karim M, Ahmed SK. Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design. Cancers (Basel). 2023 Mar 8; 15 (6) Epub 2023 Mar 08
    View PubMed
  12. Long JR, Kalani MA, Goulding KA, Ashman JB, Flug JA. Carbon-fiber-reinforced polyetheretherketone orthopedic implants in musculoskeletal and spinal tumors: imaging and clinical features. Skeletal Radiol. 2023 Mar; 52 (3):393-404 Epub 2022 May 10
    View PubMed
  13. Thomson HM, Fortin Ensign SP, Edmonds VS, Sharma A, Butterfield RJ 3rd, Schild SE, Ashman JB, Zimmerman RS, Patel NP, Bryce AH, Vora SA, Sio TT, Porter AB. Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma. Clin Med Insights Oncol. 2023; 17:11795549231161878 Epub 2023 Mar 21
    View PubMed
  14. Holmes J, Liu Z, Zhang L, Ding Y, Sio TT, McGee LA, Ashman JB, Li X, Liu T, Shen J, Liu W. Evaluating large language models on a highly-specialized topic, radiation oncology physics. Front Oncol. 2023; 13:1219326 Epub 2023 July 17
    View PubMed
  15. Laughlin BS, Golafshar MA, Lin K, Goulding K, Roesler K, Vern-Gross T, Seetharam M, Zaniletti I, Ashman JB. Long-term experience with intraoperative electron radiation therapy boost in extremity sarcoma. J Surg Oncol. 2022 Dec; 126 (7):1279-1287 Epub 2022 July 20
    View PubMed
  16. Palmer JD, Klamer BG, Ballman KV, Brown PD, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial. JAMA Oncol. 2022 Dec 1; 8 (12):1809-1815
    View PubMed
  17. De La Pena NM, Singh R, Anderson ML, Koester SW, Sio TT, Ashman JB, Vora SA, Patel NP. High-Dose Frameless Stereotactic Radiosurgery for Trigeminal Neuralgia: A Single-Institution Experience and Systematic Review. World Neurosurg. 2022 Nov; 167:e432-e443 Epub 2022 Aug 13
    View PubMed
  18. Laughlin BS, Ashman JB, Rule WG, Yu NY, Sio TT. Excellent clinical outcomes can be achieved with neoadjuvant chemoradiation and orthotopic liver transplantation for unresectable cholangiocarcinoma: support for the need of an international transplant protocol. J Gastrointest Oncol. 2022 Oct; 13 (5):2699-2700
    View PubMed
  19. Park J, Venkatesulu BP, Kujundzic K, Katsoulakis E, Solanki AA, Puckett LL, Kapoor R, Chapman CH, Hagan M, Kelly MD, Palta J, Ashman JB, Jacqmin D, Kachnic LA, Minsky BD, Olsen J, Raldow AC, Wo JY, Dawes S, Wilson E, Kudner R, Das P. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. Pract Radiat Oncol. 2022 Sep-Oct; 12 (5):424-436 Epub 2022 June 11
    View PubMed
  20. Laughlin BS, Golafshar MA, Ahmed S, Prince M, Anderson JD, Vern-Gross T, Seetharam M, Goulding K, Petersen I, DeWees T, Ashman JB. Early Experience Using Proton Beam Therapy for Extremity Soft Tissue Sarcoma: A Multicenter Study. Int J Part Ther. 2022 Summer; 9(1):1-11. Epub 2022 May 06.
  21. Laughlin BS, Petersen MM, Yu NY, Anderson JD, Rule WG, Borad MJ, Aqel BA, Sonbol MB, Mathur AK, Moss AA, Bekaii-Saab TS, Ahn DH, DeWees TA, Sio TT, Ashman JB. Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, definitive, or liver transplant-based neoadjuvant chemoradiotherapy strategies: a single-center experience. J Gastrointest Oncol. 2022 Feb; 13 (1):288-297
    View PubMed
  22. Gits HC, Tang AH, Harmsen WS, Bamlet WR, Graham RP, Petersen GM, Smyrk TC, Mahipal A, Kowalchuk RO, Ashman JB, Rule WG, Owen D, Neben Wittich MA, McWilliams RR, Halfdanarson T, Ma WW, Sio TT, Cleary SP, Truty MJ, Haddock MG, Hallemeier CL, Merrell KW. Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy. J Gastrointest Oncol. 2021 Oct; 12 (5):2275-2286
    View PubMed
  23. Mohiuddin JJ, Jethwa KR, Grandhi N, Breen WG, Wang X, Anvari A, Lin H, Sandhyavenu H, Doucette A, Plastaras JP, Rule WG, Metz JM, Merrell KW, Sio TT, Ashman JB, Haddock MG, Ben-Josef E, Hallemeier CL, Wojcieszynski AP. Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus. Adv Radiat Oncol. 2021 Sep-Oct; 6 (5):100744 Epub 2021 June 24
    View PubMed
  24. Feng H, Shan J, Ashman JB, Rule WG, Bhangoo RS, Yu NY, Chiang J, Fatyga M, Wong WW, Schild SE, Sio TT, Liu W. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma. Med Phys. 2021 Aug; 48 (8):4636-4647 Epub 2021 June 24
    View PubMed
  25. Bhangoo RS, Mullikin TC, Ashman JB, Cheng TW, Golafshar MA, DeWees TA, Johnson JE, Shiraishi S, Liu W, Hu Y, Merrell KW, Haddock MG, Krishnan S, Rule WG, Sio TT, Hallemeier CL. Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience. Adv Radiat Oncol. 2021 Jul-Aug; 6 (4):100675 Epub 2021 Mar 02
    View PubMed
  26. Ueberroth BE, Liu AJ, Starr JS, Hobday TJ, Ashman JB, Mishra N, Bekaii-Saab TS, Halfdanarson TR, Sonbol MB. Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options. Clin Colorectal Cancer. 2021 Jun; 20 (2):e139-e149 Epub 2020 Dec 17
    View PubMed
  27. Yang M, Rosenthal AC, Ashman JB, Craig FE. The Role and Pitfall of F18-FDG PET/CT in Surveillance of High Grade Pulmonary Lymphomatoid Granulomatosis. Curr Probl Diagn Radiol. 2021 May-Jun; 50 (3):443-449 Epub 2019 Feb 10
    View PubMed
  28. Neal MT, Richards AE, Curley KL, Patel NP, Ashman JB, Vora SA, Kalani MA. Carbon fiber-reinforced PEEK instrumentation in the spinal oncology population: a retrospective series demonstrating technique, feasibility, and clinical outcomes. Neurosurg Focus. 2021 May; 50 (5):E13
    View PubMed
  29. Breen WG, Jethwa KR, Yu NY, Spears GM, Harmsen WS, Miller RC, Ashman JB, Rule WG, Sio TT, Neben-Wittich MA, Haddock MG, Mahipal A, Truty MJ, Hallemeier CL, Merrell KW. Patient-Reported Quality of Life Before and After Chemoradiation for Intact Pancreas Cancer: A Prospective Registry Study. Pract Radiat Oncol. 2021 Jan-Feb; 11 (1):e63-e69 Epub 2020 July 23
    View PubMed
  30. Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021; 8:1169-1179 Epub 2021 Sept 24
    View PubMed
  31. Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT, Dorth J, Garcia-Aguilar J, Goff D, Jacqmin D, Kelly P, Newman NB, Olsen J, Raldow AC, Ruiz-Garcia E, Stitzenberg KB, Thomas CR Jr, Wu QJ, Das P. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021 Jan-Feb; 11 (1):13-25 Epub 2020 Oct 21
    View PubMed
  32. Parzen JS, Hartsell W, Chang J, Apisarnthanarax S, Molitoris J, Durci M, Tsai H, Urbanic J, Ashman J, Vargas C, Stevens C, Kabolizadeh P. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group. Radiat Oncol. 2020 Nov 4; 15 (1):255 Epub 2020 Nov 04
    View PubMed
  33. Feng H, Sio TT, Rule WG, Bhangoo RS, Lara P, Patrick CL, Korte S, Fatyga M, Wong WW, Schild SE, Ashman JB, Liu W. Beam angle comparison for distal esophageal carcinoma patients treated with intensity-modulated proton therapy. J Appl Clin Med Phys. 2020 Nov; 21 (11):141-152 Epub 2020 Oct 15
    View PubMed
  34. Gergelis KR, Jethwa KR, Tryggestad EJ, Ashman JB, Haddock MG, Hallemeier CL. Proton beam radiotherapy for esophagus cancer: state of the art. J Thorac Dis. 2020 Nov; 12 (11):7002-7010
    View PubMed
  35. Yu NY, Sio TT, Lyons MK, Vora SA, Turkmani A, Brown PD, Park SS, Leenstra JL, Bendok BR, Schild SE, Ashman JB. Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience. J Clin Neurosci. 2020 Oct; 80:74-78 Epub 2020 Aug 17
    View PubMed
  36. Jeans EB, Jethwa KR, Harmsen WS, Neben-Wittich M, Ashman JB, Merrell KW, Giffey B, Ito S, Kazemba B, Beltran C, Haddock MG, Hallemeier CL. Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer. Adv Radiat Oncol. 2020 Sep-Oct; 5 (5):865-870 Epub 2020 May 22
    View PubMed
  37. Bhangoo RS, DeWees TA, Yu NY, Ding JX, Liu C, Golafshar MA, Rule WG, Vora SA, Ross HJ, Ahn DH, Beamer SE, Jaroszewski DE, Hallemeier CL, Liu W, Ashman JB, Sio TT. Acute Toxicities and Short-Term Patient Outcomes After Intensity-Modulated Proton Beam Radiation Therapy or Intensity-Modulated Photon Radiation Therapy for Esophageal Carcinoma: A Mayo Clinic Experience. Adv Radiat Oncol. 2020 Sep-Oct; 5 (5):871-879 Epub 2020 May 19
    View PubMed
  38. Garda AE, Navin PJ, Merrell KW, Martenson JA, Neben Wittich MA, Haddock MG, Sio TT, Rule WG, Ashman JB, Sheedy SP, Hallemeier CL. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation. Radiother Oncol. 2020 Aug; 149:128-133 Epub 2020 May 15
    View PubMed
  39. Yu NY, DeWees TA, Liu C, Daniels TB, Ashman JB, Beamer SE, Jaroszewski DE, Ross HJ, Paripati HR, Rwigema JM, Ding JX, Shan J, Liu W, Schild SE, Sio TT. Early Outcomes of Patients With Locally Advanced Non-small Cell Lung Cancer Treated With Intensity-Modulated Proton Therapy Versus Intensity-Modulated Radiation Therapy: The Mayo Clinic Experience. Adv Radiat Oncol. 2020 May-Jun; 5 (3):450-458 Epub 2019 Aug 21
    View PubMed
  40. Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys. 2020 Feb 1; 106 (2):255-260 Epub 2019 Oct 22
    View PubMed
  41. Sharma A, Mountjoy LJ, Butterfield RJ, Zhang N, Ross HJ, Schild SE, Sio TT, Daniels TB, Paripati HR, Mrugala MM, Vora SA, Patel NP, Zimmerman RS, Ashman JB, Porter AB. Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review. Am J Clin Oncol. 2020 Feb; 43 (2):128-132
    View PubMed
  42. Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB. Clinical evaluation of fitness to drive in patients with brain metastases. Neurooncol Pract. 2019 Dec; 6 (6):484-489 Epub 2019 July 03
    View PubMed
  43. Garant A, Whitaker TJ, Spears GM, Routman DM, Harmsen WS, Wilhite TJ, Ashman JB, Sio TT, Rule WG, Neben Wittich MA, Martenson JA, Tryggestad EJ, Yoon HH, Blackmon S, Merrell KW, Haddock MG, Hallemeier CL. A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer. Pract Radiat Oncol. 2019 Nov; 9 (6):410-417 Epub 2019 July 13
    View PubMed
  44. Sio TT, Mohindra P, Yu NY, Ashman JB, Daniels TB, Merrell KW, Schild SE. The Search for Optimal Stereotactic Body Radiotherapy Dose in Inoperable, Centrally Located Non-Small-Cell Lung Cancer Continues. J Clin Oncol 2019 Oct 10; 37 (29):2697-2699 Epub 2019 Aug 29
    View PubMed
  45. Liu C, Bhangoo RS, Sio TT, Yu NY, Shan J, Chiang JS, Ding JX, Rule WG, Korte S, Lara P, Ding X, Bues M, Hu Y, DeWees T, Ashman JB, Liu W. Dosimetric comparison of distal esophageal carcinoma plans for patients treated with small-spot intensity-modulated proton versus volumetric-modulated arc therapies. J Appl Clin Med Phys. 2019 Jul; 20 (7):15-27 Epub 2019 May 21
    View PubMed
  46. Yu NY, Rule WG, Sio TT, Ashman JB, Nelson KL. Radiation Contamination Following Cremation of a Deceased Patient Treated With a Radiopharmaceutical. JAMA. 2019 Feb 26; 321 (8):803-804
    View PubMed
  47. Fega KR, Fletcher GP, Waddle MR, Peterson JL, Ashman JB, Barrs DM, Bendok BR, Patel NP, Porter AB, Vora SA. Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms. Adv Radiat Oncol. 2019 Jan-Mar; 4 (1):43-49 Epub 2018 Aug 23
    View PubMed
  48. Tung K, Rosenthal AC, Craig FE, Ashman JB, Yang M. Pitfall of (18)F-FDG PET/CT in Characterization of Relapsed Multisystem Lymphomatoid Granulomatosis. J Nucl Med Technol. 2018 Dec; 46 (4):396-397 Epub 2018 June 08
    View PubMed
  49. Hobbs CJ, Ko SJ, Paryani NN, Accurso JM, Olivier KR, Garces YI, Park SS, Hallemeier CL, Schild SE, Vora SA, Ashman JB, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):40-48 Epub 2017 Dec 26
    View PubMed
  50. Bagaria SP, Neville M, Gray RJ, Gabriel E, Ashman JB, Attia S, Wasif N. The Volume-Outcome Relationship in Retroperitoneal Soft Tissue Sarcoma: Evidence of Improved Short- and Long-Term Outcomes at High-Volume Institutions. Sarcoma. 2018; 2018:3056562 Epub 2018 July 24
    View PubMed
  51. Bagaria SP, Chang YH, Gray RJ, Ashman JB, Attia S, Wasif N. Improving Long-Term Outcomes for Patients with Extra-Abdominal Soft Tissue Sarcoma Regionalization to High-Volume Centers, Improved Compliance with Guidelines or Both? Sarcoma. 2018; 2018:8141056 Epub 2018 Apr 03
    View PubMed
  52. Fender EA, Chandrashekar P, Liang JJ, Dhar PR, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS. Coronary artery bypass grafting in patients treated with thoracic radiation: a case-control study. Open Heart. 2018; 5 (1):e000766 Epub 2018 Feb 14
    View PubMed
  53. Welch G, Ross HJ, Patel NP, Jaroszewski DE, Fleischer DE, Rule WG, Paripati HR, Ramirez FC, Ashman JB. Incidence of brain metastasis from esophageal cancer. Dis Esophagus. 2017 Sep 1; 30 (9):1-6
    View PubMed
  54. Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017 Aug; 18 (8):1049-1060 Epub 2017 July 04
    View PubMed
  55. Fender EA, Liang JJ, Sio TT, Stulak JM, Lennon RJ, Slusser JP, Ashman JB, Miller RC, Herrmann J, Prasad A, Sandhu GS. Percutaneous revascularization in patients treated with thoracic radiation for cancer. Am Heart J. 2017 May; 187:98-103 Epub 2017 Feb 20
    View PubMed
  56. Rodgersa B, Jaroszewski DE, Ashman JB, Ruleb W, Sio TT, Keole SR. Advantages of Post-Mastectomy Proton Beam Therapy in a Breast Cancer Patient With Pectus Excavatum. Journal of Medical Cases.2017 Mar;8:(3):98-101.
  57. Qu XM, Louie AV, Ashman J, Wasif N. Cost-Effectiveness Analysis of Preoperative Versus Postoperative Radiation Therapy in Extremity Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys. 2017 Feb 1; 97 (2):339-346 Epub 2016 Oct 19
    View PubMed
  58. Day RW, Jaroszewski D, Chang YH, Ross HJ, Paripati H, Ashman JB, Rule WG, Harold KL. Incidence and impact of postoperative atrial fibrillation after minimally invasive esophagectomy. Dis Esophagus. 2016 Aug; 29 (6):583-8 Epub 2015 Mar 30
    View PubMed
  59. Sio TT, Merrell KW, Beltran CJ, Ashman JB, Hoeft KA, Miller RC, Whitaker TJ, Wurgler SK, Tryggestad EJ. Spot-scanned pancreatic stereotactic body proton therapy: A dosimetric feasibility and robustness study. Phys Med. 2016 Feb; 32 (2):331-42 Epub 2016 Feb 13
    View PubMed
  60. Anand A, Bues M, Rule WG, Keole SR, Beltran CJ, Yin J, Haddock MG, Hallemeier CL, Miller RC, Ashman JB. Scanning proton beam therapy reduces normal tissue exposure in pelvic radiotherapy for anal cancer. Radiother Oncol. 2015 Dec; 117 (3):505-8 Epub 2015 Nov 17
    View PubMed
  61. Rule WG, Foster NR, Meyers JP, Ashman JB, Vora SA, Kozelsky TF, Garces YI, Urbanic JJ, Salama JK, Schild SE. Prophylactic cranial irradiation in elderly patients with small cell lung cancer: findings from a North Central Cancer Treatment Group pooled analysis. J Geriatr Oncol. 2015 Mar; 6 (2):119-26 Epub 2014 Dec 04
    View PubMed
  62. Keole S, Ashman JB, Daniels TB. Proton therapy for sarcomas. Cancer J. 2014 Nov-Dec; 20(6):409-14.
    View PubMed
  63. Schild SE, Rule WG, Ashman JB, Vora SA, Keole S, Anand A, Liu W, Bues M. Proton beam therapy for locally advanced lung cancer: A review. World J Clin Oncol. 2014 Oct 10; 5 (4):568-75
    View PubMed
  64. Stucky CC, Wasif N, Ashman JB, Pockaj BA, Gunderson LL, Gray RJ. Excellent local control with preoperative radiation therapy, surgical resection, and intra-operative electron radiation therapy for retroperitoneal sarcoma. J Surg Oncol. 2014 Jun; 109(8):798-803. Epub 2014 Feb 21.
    View PubMed
  65. Bagaria SP, Ashman JB, Daugherty LC, Gray RJ, Wasif N. Compliance with National Comprehensive Cancer Network guidelines in the use of radiation therapy for extremity and superficial trunk soft tissue sarcoma in the United States. J Surg Oncol. 2014 Jun; 109 (7):633-8 Epub 2014 Jan 24
    View PubMed
  66. Warner S, Chang YH, Paripati H, Ross H, Ashman J, Harold K, Day R, Stucky CC, Rule W, Jaroszewski D. Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy. Ann Thorac Surg. 2014 Feb; 97 (2):439-45 Epub 2013 Nov 20
    View PubMed
  67. Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M. Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer. J Gastrointest Oncol. 2013 Dec; 4 (4):352-60
    View PubMed
  68. Schwartz A, Rebecca A, Smith A, Casey W, Ashman J, Gunderson L, Curtis K, Chang YH, Beauchamp C. Risk factors for significant wound complications following wide resection of extremity soft tissue sarcomas. Clin Orthop Relat Res. 2013 Nov; 471 (11):3612-7 Epub 2013 June 28
    View PubMed
  69. Gunderson LL, Ashman JB, Haddock MG, Petersen IA, Moss A, Heppell J, Gray RJ, Pockaj BA, Nelson H, Beauchamp C. Integration of radiation oncology with surgery as combined-modality treatment. Surg Oncol Clin N Am. 2013 Jul; 22(3):405-32. Epub 2013 Mar 13.
    View PubMed
  70. Samuelian JM, Callister MD, Ashman JB, Young-Fadok TM, Borad MJ, Gunderson LL. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82 (5):1981-7 Epub 2011 Apr 07
    View PubMed
  71. Curtis KK, Ashman JB, Beauchamp CP, Schwartz AJ, Callister MD, Dueck AC, Gunderson LL, Fitch TR. Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities. Radiat Oncol. 2011 Aug 9; 6:91 Epub 2011 Aug 09
    View PubMed
  72. Soman AD, Collins JM, DePetris G, Decker GA, Silva A, Moss A, Greer W, Ashman J, Callister M, Borad MJ. Isolated supraclavicular lymph node metastasis in pancreatic adenocarcinoma: a report of three cases and review of the literature. JOP. 2010; 11(6):604-9. Epub 2010 Nov 09.
    View PubMed
  73. Saraceni C, Ashman JB, Harrop JS. Extracranial radiosurgery--applications in the management of benign intradural spinal neoplasms. Neurosurg Rev. 2009 Apr; 32(2):133-40; discussion 140-1. Epub 2009 Jan 28.
    View PubMed
  74. Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 1. 2005 Nov 1; 63: (3)765-71.
  75. Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, Yorke ED, Schoder H, Hsiao W, Squire OD, Vernon P, Ashman JB, Mostafavi H, Larson SM, Humm JL. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med. 2004 Aug; 45(8):1287-92.
    View PubMed
  76. Ashman JB, Connell PP, Yamada D, Rotmensch J, Waggoner SE, Mundt AJ. Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol. 2001 Aug; 82(2):338-43.
    View PubMed
  77. Ashman JB, Miller J. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J Immunol 1. 1999 Sep 1; 163: (5)2704-12.
  78. Ashman JB, Hall ES, Eveleth J, Boekelheide K. Tau, the neuronal heat-stable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. Biol Reprod. 1992 Jan; 46(1):120-9.
    View PubMed
PST-20225233